Title

Luspatercept for beta-thalassemia – A new horizon?

Department

Medicine

Document Type

Article

Publication Title

European Oncology and Haematology

Abstract

Several treatment options are being explored to reduce the transfusion burden and improve quality of life for patients with beta-thalassemia. One such prospect is the drug luspatercept, which has recently been approved for use in the USA for the treatment of beta-thalassemia. However, socioeconomic factors may act as a barrier to its widespread use.

First Page

16

Last Page

17

DOI

10.17925/EOH.2020.16.1.16

Publication Date

1-1-2020

Share

COinS